Examination of four 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: Initial studies in mouse tumor models

Nuclear Medicine and Biology - Tập 24 - Trang 587-593 - 1997
Rikki N. Waterhouse1, Janette Chapman1, Beverley Izard1, Angela Donald1, Kerynne Belbin1, Joanne C. O'Brien1, Thomas Lee Collier1
1Radiopharmaceuticals Division, Australian Nuclear Science and Technology Organisation, PMB 1 Menai N. S. W. 2234 Australia

Tài liệu tham khảo

Bem, 1991, Overexpression of σ receptors in nonneural human tumors, Cancer Res., 51, 6558 Collier, T. L., O'Brien, J. C. and Waterhouse, R. N. Synthesis of [18F]1-(3-Fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: A potential σ-1 receptor radioligand for PET. J. Labelled Compds Radiopharm. (in press). Eckelman, 1993, The design of site-directed radiopharmaceuticals for use in drug discovery, 113 Hanson, 1988, The development and application of ipso electrophilic radioiodestannylation in radiopharmaceutical chemistry, vol 2, 80 Hashimoto, 1994, Imaging sigma receptors and cerebral responses to sigma drugs, 225 Jewell, 1993, Strain Differences in rat brain and liver simga binding: Lack of cytochrome P450-2D1 involvement, Eur. J. Pharmacol., 243, 249, 10.1016/0014-2999(93)90182-H John, 1994, Synthesis and characterization of [125I]N-(benzylpiperidine-4-yl)-4-iodobenzamide, a new σ receptor radiopharmaceutical: High affinity binding to MCF-7 breast tumor cells, J. Med. Chem., 37, 1737, 10.1021/jm00038a002 John, 1993, A malignant melanoma imaging agent: Synthesis, characterisation, in vitro binding and biodistribution of iodine-125-(2-Piperidinylaminoethyl)-4-Iodobenzamide, J. Nucl. Med., 34, 2169 Leitner, 1994, Regional variation in the ratio of σ-1 to σ-2 binding in rat brain, Eur. J. Pharmacol., 259, 65, 10.1016/0014-2999(94)90158-9 Michelot, 1993, Phase II scintigraphic clinical trials of malignant melanoma and metastases with iodine-123-N(2-diethylaminoethyl-4-iodobenzamide), J. Nucl. Med., 34, 1260 Michelot, 1991, Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma, J. Nucl. Med., 32, 1573 Jain R. K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6(34), 559–593. Taylor, 1992, Identification and characterization of sigma recognition sites on established tumors and tumors cell lines, Soc. Neurosci. Abstr., 18, 455 Vilner, 1995, Sigma receptors are expressed in a wide variety of human and rodent tumor cell lines, Cancer Res., 55, 408 Waterhouse, 1996, Synthesis of [123I]-1-(trans-iodopropen-2-yl)-4-(4-cyanophenoxymethyl)piperidine: A selective σ receptor radioligand for SPECT, J. Labelled Compds. Radiopharm., 38, 215, 10.1002/(SICI)1099-1344(199603)38:3<215::AID-JLCR834>3.0.CO;2-F Waterhouse, 1996, Synthesis of a selective σ receptor radioligand for SPECT: [123I]-1-(2-hydroxyethyl)-4-(4-iodophenoxymethyl)piperidine, J. Labelled Compds. Radiopharm., 38, 595, 10.1002/(SICI)1099-1344(199607)38:7<595::AID-JLCR882>3.0.CO;2-A Waterhouse, 1995, Synthesis and in vivo evaluation of [123I]-1-(2-hydroxyethyl)-4-[(4-iodophenoxy)methyl]piperidine: A novel σ receptor ligand that exhibits high uptake in B16 melanoma in mice, J. Labelled Compounds Radiopharm., 37, 266 Waterhouse, 1995, In vivo evaluation of three novel [I-123]-labeled σ receptor ligands exhibiting high cortical uptake in rats, J. Nucl. Med., 36, 124P Waterhouse, 1997, In vivo evaluation of [18F]-1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine as a potential sigma-1 receptor ligand for PET, Nucl. Med. Biol., 24, 127, 10.1016/S0969-8051(96)00184-9 Waterhouse R. N., Mardon K. and O'Brien J. C. Synthesis and preliminary evaluation of [123I]1-(4-cyanobenzyl-4-[[(trans-iodopropen-2-yl) oxy]methyl]piperidine: A novel high affinity sigma receptor radioligand for SPECT. Nucl. Med. Biol. (in press). Waterhouse, 1996 Waterhouse, 1996, Characterisation of three [I-123]-labeled sigma receptor ligands as potential tumour imaging agents for SPECT Waterhouse, 1996, Pharmacological and SPECT evaluation of [I-123]TPCNE, a selective radioligand for the sigma-1 receptor Waterhouse, 1997, Halogenated 4-(Phenoxymethyl)piperidines as Radiolabeled Probes for Sigma Receptors: Preliminary In Vivo Evaluation of [123I]1-(Iodopropen-2-yl)-4-(4-cyanophenoxymethyl)-piperidine, J. Med. Chem., 40, 1657, 10.1021/jm960720+ Webster, 1985, Environmental fate modelling of chlorodioxins: Determination of physical constants, Chemosphere, 14, 609, 10.1016/0045-6535(85)90169-9